Current status of pharmacogenomics testing for anti-tumor drug therapies: approaches to non-melanoma skin cancer.


Skin cancer is one of the most commonly occurring cancer types, with substantial social, physical, and financial burdens on both individuals and societies. Although the role of UV light in initiating skin cancer development has been well characterized, genetic studies continue to show that predisposing factors can influence an individual's susceptibility to… (More)
DOI: 10.2165/01250444-200913020-00001


  • Presentations referencing similar topics